Mika Scheinin
MD, PhD, Professor Emeritus
Bioanalytics; Clinical Pharmacology; Drug Development; Positron Emission Tomography; Research Ethics
- Dexmedetomidine decreases serum insulin concentrations and this response is influenced by alpha2a adrenoceptor genetic variation (2012)
- Clinical Pharmacology and Therapeutics
- Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease (2012)
- Archives of Neurology -Chigago-
- G-proteiinikytkentäiset reseptorit merenkulun palveluksessa: stressilääkkeen uusi käyttöaihe (2012)
- Sphinx
- High-throughput screening with a miniaturized radioligand competition assay identifies new modulators of human α2-adrenoceptors. (2012)
- European Journal of Pharmaceutical Sciences
- Influence of MK-467, a peripherally acting α2-adrenoceptor antagonist on the disposition of intravenous dexmedetomidine in dogs. (2012)
- Drug Metabolism and Disposition
- Involvement of α2-adrenoceptor subtypes A and C in glucose homeostasis and adrenaline-induced hyperglycaemia. (2012)
- Neuroendocrinology
- Lääkeaineiden vaikutusmekanismit: reseptorit (2012) Farmakologia ja toksikologia Scheinin Mika
- Might the observed α2A-adrenoceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? (2012)
- Bioorganic and Medicinal Chemistry
- Pharmacokinetics of [F-18]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease (2012)
- European Journal of Nuclear Medicine and Molecular Imaging
- Synthesis and biological activities of 2- [(heteroaryl)methyl]imidazolines (2012)
- Bioorganic and Medicinal Chemistry



